These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 623439)

  • 1. Tissue polypeptide antigen (TPA): Biology, biochemistry, improved assay methodology, clinical significance in cancer and other conditions, and future outlook.
    Björklund B
    Antibiot Chemother (1971); 1978; 22():16-31. PubMed ID: 623439
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical evaluation of tumor markers in patients with lung cancer, laying stress on tissue polypeptide antigen (TPA)].
    Matsubara Y; Ninomiya K; Yasuda Y; Hanawa T; Yagi K; Miyamoto Y; Hatakenaka R; Funatsu T; Ikeda S; Kuwabara M
    Nihon Gan Chiryo Gakkai Shi; 1986 May; 21(4):744-51. PubMed ID: 3760641
    [No Abstract]   [Full Text] [Related]  

  • 3. [Distribution and prognostic value of CEA and TPA in cancer of the lung].
    Leonardo E; Dogliotti C; Mancuso M; Sanfilippo B; Oliaro A
    Minerva Med; 1986 Mar; 77(11):375-9. PubMed ID: 3703330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential immunocytochemical localization of tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) in breast cancer.
    Björklund V; Björklund B
    Cancer Detect Prev; 1983; 6(1-2):193-8. PubMed ID: 6883380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of carcinoembryonic and tissue polypeptide antigen determination in the diagnosis of metastases in breast cancer.
    Kausitz J; Hupka S; Makaiová I; Michalíková B; Urbanová M; Bohunický L; Belovicová C
    Neoplasma; 1986; 33(4):471-6. PubMed ID: 3762808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advantages and limitations of combined assays of 4 serum markers in various types of malignant neoplasms].
    Lanza E; Coda C; Ramella S; Ciambellotti E; Moro G; Cartia GL
    Minerva Med; 1986 Sep; 77(34-35):1521-5. PubMed ID: 3463886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study on the clinical usefulness of tissue polypeptide antigen in various blood diseases.
    Kageyama T; Oyabu H
    Bull Osaka Med Sch; 1983 Oct; 29(2):55-61. PubMed ID: 6680326
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunotherapy of human tumors.
    Sinkovics JG
    Pathobiol Annu; 1978; 8():241-84. PubMed ID: 364375
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined use of carcinoembryonic antigen and tissue polypeptide antigen in oncologic therapy and surveillance.
    Lüthgens M; Schlegel G
    Cancer Detect Prev; 1983; 6(1-2):51-9. PubMed ID: 6883393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunodiagnosis and its applicability for cancer screening.
    Heberman RB
    Antibiot Chemother (1971); 1978; 22():59-66. PubMed ID: 341798
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical usefulness of serum TPA (tissue polypeptide antigen) in postsurgical diagnosis, prognosis and follow-up of lung cancer.
    Volpino P; Cangemi V; Caputo V; Graziani EP; Mazzarino E; Gentili S; Borghese M
    J Nucl Med Allied Sci; 1985; 29(3):241-4. PubMed ID: 4078636
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of cancer upon high-density and other lipoproteins.
    Barclay M; Skipski VP; Terebus-Kekish O; Greene EM; Kaufman RJ; Stock CC
    Cancer Res; 1970 Sep; 30(9):2420-30. PubMed ID: 5529116
    [No Abstract]   [Full Text] [Related]  

  • 13. [Preliminary results of the clinical use of TPA (tissue polypeptide antigen)].
    Dalla Pria AF; Guolo P; Piaserico PL; Ricci G; Berlanda G; Gobbi V; Minello S
    Arch De Vecchi Anat Patol; 1983 Jul; 65(2-3):301-13. PubMed ID: 6680294
    [No Abstract]   [Full Text] [Related]  

  • 14. Proton nuclear magnetic resonance spectroscopy of plasma from healthy subjects and patients with cancer.
    Engan T; Krane J; Klepp O; Kvinnsland S
    N Engl J Med; 1990 Apr; 322(14):949-53. PubMed ID: 2314446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phagocytic potential of the blood in malignant tumors].
    Sokolova NM; Klechikov LZ
    Vrach Delo; 1967 May; 5():33-7. PubMed ID: 5618536
    [No Abstract]   [Full Text] [Related]  

  • 16. [Importance of the tissue polypeptide antigen level in neoplastic patients. Its correlation with other tumor markers].
    Ruibal A; Durán P; Lafuerza A; Bodi R; Solé LA; Rubio D; Ibarz L; De Torres JA; Domenech-Torné FM; Salvador L
    Rev Esp Oncol; 1984; 31(3):409-14. PubMed ID: 6546169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Behavior of serum sialic acid levels at various stages of neoplastic disease].
    Adamo V; Altavilla G; Caristi N; Chillemi S; Giacobello T; Scalisi R; Palmara D
    Minerva Med; 1985 Nov; 76(43):2067-70. PubMed ID: 4069416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biochemical markers of neoplasms of the female genital organs. I. Tissue polypeptide antigen (TPA)].
    Kamiński K
    Ginekol Pol; 1988 Dec; 59(12):739-43. PubMed ID: 3076162
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical significance of tissue polypeptide antigen (TPA) and carbohydrate antigen 12-5 (CA 12-5) in the sera from patients with various gynecologic tumors].
    Tohya T; Inoue S; Tanaka N; Fujisaki S; Maeyama M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2872-5. PubMed ID: 3910744
    [No Abstract]   [Full Text] [Related]  

  • 20. [Tissue polypeptide antigen in breast cancer].
    Nomizu T; Watanabe I; Endo S
    Nihon Gan Chiryo Gakkai Shi; 1984 Dec; 19(10):2287-95. PubMed ID: 6085339
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.